Cours suspendu

Autres langues Accolade, Inc.

Actions

ACCD

US00437E1029

Installations et services en soins de santé

Marché Fermé - Nasdaq 22:00:00 07/04/2025			Varia. 5j.	Varia. 1 janv.
7,020 ^USD	-0,14%		-.--%	-

13/04	Accolad Technologies dévoile une nouvelle génération de catalogues de cadeaux de reconnaissance	CI
08/04/25	Accolade, Inc. annonce des départs du conseil d'administration	CI

Autres langues

13/04	Accolad Technologies Unveils New Generation of Recognition Gift Catalogs
09/04/25	Transcarent Completes Merger with Accolade
08/04/25	Accolade, Inc. Announces Board Cessations
08/04/25	Accolade, Inc.(NasdaqGS:ACCD) dropped from NASDAQ Composite Index
08/04/25	Transcarent, Inc completed the acquisition of Accolade, Inc. from a group of shareholders.
08/04/25	Accolade, Inc.(NasdaqGS:ACCD) dropped from S&P Global BMI Index
08/04/25	Accolade, Inc.(NasdaqGS:ACCD) dropped from S&P TMI Index
27/03/25	Accolade Stockholders Approve Merger Between Accolade And Transcarent
27/03/25	Accolade Shareholders Greenlight Merger With Transcarent
27/03/25	Accolade Stockholders Approve Merger Between Accolade and Transcarent
06/03/25	Accolade Welcomes Oshi Health to Trusted Partner Ecosystem
06/03/25	Accolade Welcomes Oshi Health to Trusted Partner Ecosystem
24/02/25	Transcarent and Accolade Announce Expiration of Hart-Scott Rodino Waiting Period for Pending Merger Transaction
04/02/25	Accolade Expands Virtual Care to Medicare Beneficiaries Nationwide Through PlushCare Direct-to-Consumer Offering
10/01/25	Accolade: Fiscal Q3 Earnings Snapshot
10/01/25	Accolade, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended November 30, 2024
08/01/25	ACCOLADE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Accolade, Inc. - ACCD
08/01/25	Sector Update: Health Care Stocks Advance Late Afternoon
08/01/25	Accolade to be Acquired, Taken Private by Transcarent in $621 Million Deal
08/01/25	Accolade Agrees to be Acquired, Brought Private by Transcarent in $621 Million Deal
08/01/25	Transcarent To Acquire Accolade
08/01/25	Transcarent To Acquire Accolade
23/12/24	Accolade, Inc.(NasdaqGS:ACCD) dropped from S&P Health Care Services Select Industry Index
16/12/24	Accolade to Announce Fiscal Third Quarter 2025 Financial Results
13/11/24	Accolade To Present at Upcoming Investor Conferences